Agenus [6t6tsMMmbMo]
Tag: #Trento - Olimpia Milano, #bobby brown, #canvas, #donovan mitchell
#AGEN Agenus 2025 Full Year Earnings: Agenus reported significant progress in their BOT+BAL immunotherapy program with promising clinical data and strategic collaborations in 2025.
- Revenue: $4.2 million pre-commercial
- Adj. EPS: -$1.26 forecast
- Zydus Collaboration: $91 million upfront
- Phase 3 lnp Trial: Initiated
"BOT+BAL is beginning to stand out for the reasons that matter most; patients with few options are actively seeking access, physicians are gaining experience with the regimen, and the clinical foundation continues to strengthen," said Garo H. Armen, PhD, Chairman and CEO of Agenus.
If you enjoyed this video, please like, subscribe, and hit the notification bell to stay updated with our latest stock analysis and market insights. Leave a comment below with your thoughts on the video, and any other stocks you'd like us bec and danny mafs to cover.
*Check out our latest videos on more earnings:*
- #WW Weight Watchers 2025 Q4 & Full Year Earnings:
- #LFCR Lifecore 2025 Transition Period Earnings:
- #TLS Telos 2025 Q4 & Full Year Earnings:
- #OPAL coliform bacteria OPAL Fuels 2025 Q4 & Full Year Earnings:
- #VNET VNET 2025 Q4 & Full Year Earnings: